Sign inGet started

Gibbs Craig S

Insider CIK 1614856 · ARDS Director · FTSV Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARDS Aridis Pharmaceuticals, In A Award deriv2022-12-052022-12-0710,000— $010,000SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2021-10-042021-10-057,900— $060,040SEC↗
FTSV Forty Seven, Inc. D To issuer deriv2020-04-072020-04-07112,903— $00SEC↗
FTSV Forty Seven, Inc. D To issuer deriv2020-04-072020-04-0760,235— $00SEC↗
FTSV Forty Seven, Inc. D To issuer deriv2020-04-072020-04-0764,515— $00SEC↗
FTSV Forty Seven, Inc. D To issuer deriv2020-04-072020-04-0772,902— $00SEC↗
FTSV Forty Seven, Inc. D To issuer2020-04-072020-04-079,124— $00SEC↗
FTSV Forty Seven, Inc. D To issuer2020-04-072020-04-0747,327— $00SEC↗
FTSV Forty Seven, Inc. D To issuer2020-04-072020-04-0747,327— $00SEC↗
FTSV Forty Seven, Inc. D To issuer2020-04-072020-04-075,924— $00SEC↗
FTSV Forty Seven, Inc. G Gift2020-04-012020-04-079,124— $09,124SEC↗
FTSV Forty Seven, Inc. A Award deriv2019-12-132019-12-1760,235— $060,235SEC↗
FTSV Forty Seven, Inc. G Gift2019-09-172019-09-259,124— $018,248SEC↗
FTSV Forty Seven, Inc. G Gift2019-09-172019-09-259,124— $047,327SEC↗
FTSV Forty Seven, Inc. G Gift2019-09-172019-09-259,124— $09,124SEC↗
FTSV Forty Seven, Inc. G Gift2019-09-172019-09-259,124— $047,327SEC↗
ARDS Aridis Pharmaceuticals, In A Award deriv2019-08-132019-08-1435,000— $052,140SEC↗